ReviewFrontiers in immunology2022
Targeting 4-1BB for tumor immunotherapy from bench to bedside.
Ya-Tao Wang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
7 papers cite it
this papercites it
ReviewFrontiers in immunology2022
Ya-Tao Wang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.